GST-HG151
/ Fujian Cosunter
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 26, 2022
Phase I Study of GST-HG151 Tablets in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=112 | Recruiting | Sponsor: Fujian Cosunter Pharmaceutical Co. Ltd
New P1 trial
1 to 1
Of
1
Go to page
1